Search Within

Robert Motzer

  1. "Biostatistics Service"
Formats
  1. Journal Article (62)
  2. Meeting Abstract (60)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (123)
  2. Department of Medicine (123)
  3. Epidemiology and Biostatistics (123)
  4. Genitourinary Oncology Service (123)
  5. Solid Tumor Oncology Division (123)
  6. Surgery (72)

More Groups

People
  1. Sujata Patil (93)
  2. Darren Feldman (78)
  3. Martin Voss (58)
  4. Abraham Hakimi (42)
  5. George Bosl (33)
  6. Chung-Han Lee (31)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (65)
  2. Cancer (8)
  3. Clinical Genitourinary Cancer (8)
  4. Clinical Cancer Research (4)
  5. Investigational New Drugs (3)
  6. Journal of Urology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. Elsevier Inc. (12)
  3. Wiley Blackwell (10)
  4. American Association for Cancer Research (6)
  5. Elsevier Science, Inc. (5)
  6. Nature Publishing Group (4)

More Publishers

Results (123)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improvement in overall survival of patients with advanced renal cell carcinoma: Prognostic factor trend analysis from an international data set of clinical trials
    Journal Article

    Patil, S.; Manola, J.; Elson, P.; Negrier, S.; Escudier, B.; Eisen, T.; Atkins, M.; Bukowski, R.; Motzer, R. J.
    Journal of Urology (2012)

    Fulltext@MSK | Save
  • Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-α
    Journal Article

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    British Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Voss, M. H.; Ginsberg, M. S.; Baum, M. S.; Brocks, D. R.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Journal Article

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Kroog, G.; Tickoo, S. K.; Jia, X.; Georges, M.; Patil, S.; Baum, M. S.; Reuter, V. E.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
    Journal Article

    Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Cancer (2012)

    Fulltext@MSK | Save
  • Clinical features of germ cell tumors (GCT) in men age 50 or older: Successful outcome and tolerability to chemotherapy for advanced disease
    Meeting Abstract

    Voss, M. H.; Jacobsen, E. P.; Patil, S.; Turkula, S.; Jia, X.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.; Feldman, D. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Molecular classification of sunitinib response in metastatic renal cell carcinoma (mRCC) patients by gene expression profiling
    Meeting Abstract

    Thodima, V. J.; Molina, A. M.; Jia, X.; Zhang, J.; Georges, M. E.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk factor migration and survival: Analysis from international dataset of 3,748 metastatic renal cell carcinoma (mRCC) patients treated on clinical trials
    Meeting Abstract

    Patil, S.; Manola, J.; Elson, P.; Bro, W.; Negrier, S.; Escudier, B.; Bukowski, R. M.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Fischer, P.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save